Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya
Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya (0-4.5 Month Randomized Controlled Trial)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Terminated
DSMB recommended termination because TI was safe but not durable.
Other terminated trials from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
A NA clinical study on HIV Infections, this trial is terminated or withdrawn. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 8 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2022 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — May 2022 [monthly]
Terminated NA
-
Aug 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Terminated NA
-
Jun 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Jun 2017 [monthly]
Terminated NA
First recorded
Sep 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Fred Hutchinson Cancer Center
- National Institutes of Health (NIH)
- University of Nairobi
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.